Updated on 10 May 2026
Investment Opportunity for business angels and VCs – Impactful Innovation in Cardiac Prevention
CEO at Inn'Pulse
Grasse, France
About
Only 20% of employees know where the defibrillator is located at work, yet action must be taken within 3 minutes. Nearly 5 million people die from sudden cardiac arrest worldwide each year.
I co-founded Inn’Pulse to protect all organizations—businesses, associations, and public entities—from cardiac arrest by making defibrillators so intuitive that anyone can intervene in under 30 seconds, anywhere, even without training, especially in high-risk work environments.
Our project:
-
B2B, manufactured in Europe
-
18 months from CE marking/commercialization, with a secured regulatory roadmap and our notified body
-
Already secured 7 LOIs from corporates, associations, and prescribers
We are finalizing our €1M seed round (equity), to close before August 31st. Over €800K is already committed in soft-commitments, and a lead (or co-lead) ticket of €500K–€1M remains available.
Organisation
Grasse, France
Similar opportunities
Product
Inn’Pulse introduces the world’s simplest, most compact defibrillator, arriving in 2027.
- Buyer
- Investment/Finance
- Re-Seller/Wholesaler
Guillaume Pétriat
CEO at Inn'Pulse
Grasse, France
Investment
AI-Powered Pediatric Health Tech (France)
- Seed funding | Get business started
Manon Sauter 🩺
CEO at FamilleSanté
Montpellier, France
Investment
Investment in pre-series A to series C investment rounds
- Series C | Later rounds
- Series A | Scale business
- Series B | Funding expansion
Sem Alberga
Managing DIrector at KPN Ventures
Rotterdam, Netherlands